Select your timezone:

State-of-the-Art Session
Hematopoietic stem cells transplantation, classical and new indications

Wednesday September 14, 2022 | 19:00 to 20:30

Learning Objectives

After this session, the attendees should be able:
- To know the state of the art about autologous hematopoietic stem cell transplantation in autoimmune diseases, indications, preparative regimens, and complications
- To increase knowledge about donor selection, use of different preparative regimens, and relapse prevention strategies in patients with acute leukemia
- To understand the mechanisms by which an allogeneic hematopoietic stem cell transplant can prevent the rejection of a solid organ transplant
- To know the available strategies for the prevention and treatment of PTLD


Prof. Maria Carolina O Rodrigues, Brazil
Autologous HSCT in autoimmune diseases (EG: multiple sclerosis)

Damiano Rondelli, United States
Allogeneic HSCT in ALL/AML. The best donor, conditioning, prevention of relapse

Prof. Ephraim J Fuchs, United States
Allo HSCT as inducing immune tolerance to solid organs transplantation

Ibrahim Yakoub-Agha, France
CAR T cells therapy

© 2022 TTS 2022